June 24, 2025 Beyond Just NAION: Ozempic and Wegovy Linked to Increased Risk of Vision Loss A new study in JAMA Ophthalmology has added another entry to the growing ledger of concerns about Ozempic and Wegovy, with yet more concerns involving the loss of vision
[1] [4] For breastfeeding mothers with type 2 diabetes, the priority is achieving safe and effective glycaemic control while minimising any risk to the infant
Facial Aesthetics Botox and Dysport for wrinkle reduction treatment
Whether you're working to lose weight, manage cravings, or maintain a balanced diet, understanding GLP-1 and its role in appetite control is a great place to start
GLP-1s are currently prescribed in the general population to manage type 2 diabetes and obesity by helping regulate appetite and blood sugar levels
Treatment with semaglutide tablets 14 mg once daily for 26 weeks resulted in a statistically significant reduction in HbA1c compared to empagliflozin 25 mg once daily (see Table 5)